Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs

por Ghorab, Ahmad, Al-Kali, Aref, Elliot, Michelle, Gangat, Naseema, Alkhateeb, Hasan, Shah, Mithun, Liu, Yuanhang, Yi, Cecilia Arana, Murthy, Hemant, Kharfan-Dabaja, Mohamed, Tefferi, Ayalew, Patnaik, Mrinal, Litzow, Mark, Badar, Talha
Publicado 2022

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid...

por Abou Dalle, Iman, Ghorab, Ahmad, Patel, Keyur, Wang, Xuemei, Hwang, Hyunsoo, Cortes, Jorge, Issa, Ghayas C., Yalniz, Fevzi, Sasaki, Koji, Chihara, Dai, Price, Allyson, Kadia, Tapan, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney, Ravandi, Farhad, Kantarjian, Hagop M., Borthakur, Gautam
Publicado 2020